FDA recall D-0101-2021

Hikma Pharmaceuticals USA Inc. · Class II · drug

Product

Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For use as a sterile diluent, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, a) Vial NDC 0641-0497-17, b) Carton of 25 vials NDC 0641-0497-25.

Reason for recall

Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2 mL vial.

Distribution

Nationwide in the U.S.

Key facts

Status
Terminated
Initiation date
2020-11-03
Report date
2020-11-25
Termination date
2022-11-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cherry Hill, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0101-2021